• Explore /
  • Poster
  • / Activity and tolerability of maintenance avelumab (AVE) immunotherapy after first-line platinum-based polychemotherapy in patients (pts) with locally advanced or metastatic squamous cell penile carcinoma: Initial results of PULSE study.

Activity and tolerability of maintenance avelumab (AVE) immunotherapy after first-line platinum-based polychemotherapy in patients (pts) with locally advanced or metastatic squamous cell penile carcinoma: Initial results of PULSE study.

Abstract Poster

Authors

null

Antoine Thiery-Vuillemin

Medical Oncology, Centre Hospitalier Régional Universitaire, Besancon, France

Antoine Thiery-Vuillemin , Sophie Tartas , Loic Mourey , Emeline Colomba , Delphine Borchiellini , Morgan Goujon , Felix Lefort , Delphine Topart , Philippe Barthelemy , Geraldine Lauridant , Aurelia Meurisse , Dewi Vernerey , Vincent Massard

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03774901

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 8)

DOI

10.1200/JCO.2023.41.6_suppl.8

Abstract #

8

Poster Bd #

D13

Abstract Disclosures

Similar Posters

First Author: Amit Bahl

First Author: Wei Wang

First Author: Emily Renninson

First Author: Roberto Iacovelli